In conclusion, these links between RBP4 and HCC malignancy, metabolic regulation, and immune cell infiltration support the idea of a protective role for RBP4 in HCC, and for its use in predicting HCC outcomes. Here, RBP4 is linked to hepatocellular carcinoma.